These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 20553059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
    O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD005326. PubMed ID: 16856092
    [Abstract] [Full Text] [Related]

  • 3. Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database.
    Breart G, Cooper C, Meyer O, Speirs C, Deltour N, Reginster JY.
    Osteoporos Int; 2010 Jul 19; 21(7):1181-7. PubMed ID: 19806285
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism.
    Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L.
    Osteoporos Int; 2010 Sep 19; 21(9):1591-7. PubMed ID: 19859641
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
    Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY.
    Osteoporos Int; 2009 Oct 19; 20(10):1663-73. PubMed ID: 19153678
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.
    Kaufman JM, Audran M, Bianchi G, Braga V, Diaz-Curiel M, Francis RM, Goemaere S, Josse R, Palacios S, Ringe JD, Felsenberg D, Boonen S.
    J Clin Endocrinol Metab; 2013 Feb 19; 98(2):592-601. PubMed ID: 23341486
    [Abstract] [Full Text] [Related]

  • 14. [Adverse drug reactions of strontium ranelate(Protelos(®) in France].
    Jonville-Bera AP, Autret-Leca E.
    Presse Med; 2011 Oct 19; 40(10):e453-62. PubMed ID: 21885232
    [Abstract] [Full Text] [Related]

  • 15. Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.
    Deeks ED, Dhillon S.
    Drugs; 2010 Apr 16; 70(6):733-59. PubMed ID: 20394457
    [Abstract] [Full Text] [Related]

  • 16. A large prospective European cohort study of patients treated with strontium ranelate and followed up over 3 years.
    Audran M, Jakob FJ, Palacios S, Brandi ML, Bröll H, Hamdy NA, McCloskey EV.
    Rheumatol Int; 2013 Sep 16; 33(9):2231-9. PubMed ID: 23455629
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
    Stevenson M, Davis S, Lloyd-Jones M, Beverley C.
    Health Technol Assess; 2007 Feb 16; 11(4):1-134. PubMed ID: 17280622
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.